It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies.
Haematologica
; 107(3): 572-573, 2022 03 01.
Article
in English
| MEDLINE | ID: covidwho-1714972
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Haematologica
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS